Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma

Irradiation and temozolomide (TMZ) chemotherapy are the current standard treatments for glioblastoma multiforme (GBM), but they are associated with toxicity and limited efficacy. Recently, these standard therapies have been used to enhance immunotherapy against GBM. Immunotherapy using the anti-CD47...

Descripción completa

Detalles Bibliográficos
Autores principales: Gholamin, Sharareh, Youssef, Osama A, Rafat, Marjan, Esparza, Rogelio, Kahn, Suzana, Shahin, Maryam, Giaccia, Amato J, Graves, Edward E, Weissman, Irving, Mitra, Siddhartha, Cheshier, Samuel H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016411/
https://www.ncbi.nlm.nih.gov/pubmed/31547758
http://dx.doi.org/10.1177/1753425919876690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016411/
https://www.ncbi.nlm.nih.gov/pubmed/31547758
http://dx.doi.org/10.1177/1753425919876690

Ejemplares similares